These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38317868)

  • 1. The Relationship Between Health Insurance Status and Diabetic Retinopathy Progression.
    Guo Y; Copado IA; Yonamine S; Jian Ma C; McLeod S; Arnold BF; McCulloch CE; Sun CQ
    Ophthalmol Sci; 2024; 4(3):100458. PubMed ID: 38317868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy.
    Guo Y; Yonamine S; Jian Ma C; Stewart JM; Acharya N; Arnold BF; McCulloch C; Sun CQ
    Ophthalmol Sci; 2023 Jun; 3(2):100276. PubMed ID: 36950087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: Baseline Retinopathy and Clinical Features Predict Progression of Diabetic Retinopathy.
    Lee CS; Lee AY; Baughman D; Sim D; Akelere T; Brand C; Crabb DP; Denniston AK; Downey L; Fitt A; Khan R; Mahmood S; Mandal K; Mckibbin M; Menon G; Lobo A; Kumar BV; Natha S; Varma A; Wilkinson E; Mitry D; Bailey C; Chakravarthy U; Tufail A; Egan C;
    Am J Ophthalmol; 2017 Aug; 180():64-71. PubMed ID: 28572062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy.
    Kawai K; Murakami T; Mori Y; Ishihara K; Dodo Y; Terada N; Nishikawa K; Morino K; Tsujikawa A
    Ophthalmol Sci; 2023 Mar; 3(1):100241. PubMed ID: 36545265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.
    Meer E; Bavinger JC; Yu Y; VanderBeek BL
    JAMA Ophthalmol; 2022 May; 140(5):529-532. PubMed ID: 35389455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
    Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
    JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year Patterns of Diabetic Retinopathy Progression in US Clinical Practice.
    Moshfeghi A; Garmo V; Sheinson D; Ghanekar A; Abbass I
    Clin Ophthalmol; 2020; 14():3651-3659. PubMed ID: 33154625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Diabetic Retinopathy at Eye Clinic Svjetlost Sarajevo: Two Years Retrospective Single Center Study.
    Pidro A; Ahmedbegovic-Pjano M; Grisevic S; Sofic-Drino V; Gabric K; Biscevic A
    Mater Sociomed; 2019 Dec; 31(4):290-293. PubMed ID: 32082096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis.
    Yang QH; Zhang Y; Zhang XM; Li XR
    Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Diagnosis Codes to Clinical Notes in Classifying Patients with Diabetic Retinopathy.
    Yonamine S; Ma CJ; Alabi RO; Kaidonis G; Chan L; Borkar D; Stein JD; Arnold BF; Sun CQ
    Ophthalmol Sci; 2024; 4(6):100564. PubMed ID: 39253554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States.
    Willis JR; Doan QV; Gleeson M; Haskova Z; Ramulu P; Morse L; Cantrell RA
    JAMA Ophthalmol; 2017 Sep; 135(9):926-932. PubMed ID: 28750122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.
    Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
    PLoS One; 2016; 11(8):e0161897. PubMed ID: 27564383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Importance of Close Follow-Up in Patients with Early-Grade Diabetic Retinopathy: A Taiwan Population-Based Study Grading via Deep Learning Model.
    Lee CC; Hsing SC; Lin YT; Lin C; Chen JT; Chen YH; Fang WH
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
    Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
    Ophthalmol Retina; 2018 Jan; 2(1):38-45. PubMed ID: 31047300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Incidence of Proliferative Diabetic Retinopathy and Associated Risk Factors in a Nationwide Cohort of 201 945 Danish Patients with Diabetes.
    Dinesen S; Stokholm L; Subhi Y; Peto T; Savarimuthu TR; Andersen N; Andresen J; Bek T; Hajari J; Heegaard S; Højlund K; Laugesen CS; Kawasaki R; Möller S; Schielke K; Thykjær AS; Pedersen F; Grauslund J
    Ophthalmol Sci; 2023 Sep; 3(3):100291. PubMed ID: 37025947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
    Wykoff CC; Chakravarthy U; Campochiaro PA; Bailey C; Green K; Cunha-Vaz J
    Ophthalmology; 2017 Apr; 124(4):440-449. PubMed ID: 28081945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.
    Li Y; Yu Y; VanderBeek BL
    Eye (Lond); 2020 May; 34(5):934-941. PubMed ID: 31586167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of severe non-proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study.
    Sardarinia M; Asgari S; Hizomi Arani R; Eskandari F; Azizi F; Khalili D; Hadaegh F
    J Diabetes Investig; 2022 Feb; 13(2):317-327. PubMed ID: 34403198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.